Coronary artery disease (CAD) arising from atherosclerosis remains the most common
cause of death and morbidity worldwide, although its risk factors, such as hypertension …

Cardiovascular disease is the leading cause of death worldwide, with high medical costs
and rates of disability. It is therefore important to evaluate the use of cardiovascular …

Using bioinformatics analysis, we previously identified salusin-β, an endogenous bioactive
peptide with diverse physiological activities. Salusin-β is abundantly expressed in the …

Dyslipidemia is one of the most potent risk factors for the development of atherosclerosis.
The high atherosclerotic risk in dyslipidemic patients is associated with endothelial …

Salusin β is a bioactive peptide, detectable in many tissues and body fluids, first identified
nearly 20 years ago. Since then, many studies have been performed to define the role of …

Salusins originally identified using bioinformatics analyses have been shown to act on the
cardiovascular and endocrine systems. Although the hypotensive activity of salusin-α is …

Objective The relationship between the severity of atherosclerotic coronary artery disease
(CAD) and circulating levels of salusin-α, salusin-β and heregulin-β1 has been investigated …

Human salusin‐α and salusin‐β are related peptides produced from prosalusin. Bolus
injection of salusin‐β into rats induces more profound hypotension and bradycardia than …

Salusin-β is an endogenous parasympathomimetic proatherosclerotic peptide. Salusin-β
was initially predicted from bioinformatic analyses and later immunologically detected in …

Salusins are discovered in 2003 and divided into salusin-α and salusin-β, which are
bioactive peptides with hemodynamic and mitotic activity and mainly distributed in plasma …